As interest in the ExoVasc PEARS device grows around the world, Exstent has appointed distributors in Australia, Belgium, the Czech Republic, France, Italy, the Netherlands, New Zealand and Spain. By partnering with established distributors in these territories the company can form close links with key surgeons and offer this innovative alternative to aortic root replacement to a larger number of patients.
The first PEARS surgery recently completed in the Netherlands was the result of a patient contacting the company. The story has made the national news (see www.rtlnieuws.nl/nederland/hartpatient-introduceert-revolutionaire-operatie-in-nederland and www.amc.nl/web/ons-amc/verhalen/community/patient-introduceert-nieuwe-hartingreep.htm) and Amsterdam surgeon David Koolbergen plans to offer this surgery to further patients in the near future.
Tal Golesworthy spoke at the London Cardiothoracic Surgery Core Review Course which was held 10-13 May 2018 at the Royal Society of Medicine in London, UK.
The London Cardiothoracic Surgery Core Review Course attracts delegates from the UK and worldwide. Tal Golesworthy spoke as part of the UK Supplement, which was aimed at trainees but also a wider audience including consultants.
For more information visit www.corereview.co.uk.
On 12 April 2018 Tal Golesworthy spoke about the PEARS project at the Polish Cardiological Society, Gdansk division, which took place in Gdansk in Poland.
On 3 March 2018, Tal Golesworthy was a keynote speaker at the Imperial College Surgical Society Innovation Conference, which took place in London. Adverse weather conditions made travel impossible, so Tal presented via Skype.
The Innovation Conference is a national conference that runs annually for students to showcase inspiring stories in the field of medical innovation. The day features prominent speakers, workshops, and also a “Hackathon” to encourage medical flair and innovation. The theme of this year’s conference was Implants and Wearables.
On 5 December 2017, Tal Golesworthy spoke about the PEARS project at UK HealthTech 2017. The event took place in Cardiff, UK and gave the latest insights on critical strategic trends for the life science and health technology community.
To find out more about the event, visit the UK HealthTech 2017 website.
Seven papers were presented on the use of the ExoVasc Personalised External Aortic Root Support in two sessions at the European Association of Cardiothoracic Surgeons Annual meeting in Vienna on 8 October 2017. The EACTS Daily News featured a full-page article entitled An update on PEARS featuring the introductory presentation by Professor John Pepper. The subsequent presentations by five other surgeons led to a positive discussion in a dedicated session on the PEARS approach. Exstent also enjoyed a busy stand at the associated technical exhibition, where the ExoVasc support was shown to many surgeons and attracted considerable interest from distributors and cardiac surgery device manufacturers.
Six surgeons will present papers at the European Association of Cardiothoracic Surgeons Annual Meeting in Vienna on 8th October describing their experience with the ExoVasc Personalised External Aortic Root Support. The papers being presented are as follows:
- John Pepper: Overview to date: practice and outcomes
- Tom Treasure: Histological mesh incorporation in sheep and man
- Ulrich Rosendahl: Fixation to the aorto-ventricular junction: why and how?
- Filip Rega: Situations and threshold for using the pump
- Mario Petrou: Personalised external aortic root support and concomitant surgery
- Conal Austin: Mesh support for situations other than for congenitally determined root aneurysm
In addition, Exstent will be present on booth 109 at the associated Technical Exhibition.
You can find out more about the conference on the EACTS website. You can also download timetable information on the PEARS presentations.
On 23 June 2017 Tal Golesworthy spoke at the Transforming Ideas event for Allied Health Professionals at Sheffield Hallam University. The subject of his presentation was Multidisciplinary Innovation in Cardiothoracic Surgery.
Tal Golesworthy gave the closing speech at Medforce Europe in Hamburg on 6 June 2017. The subject of his talk was patient-driven innovation, with particular reference to the PEARS project. Medforce Europe is aimed at sales and marketing professionals working in the medical device industry and the event features senior speakers from industry-leading companies. For more information, visit medforceeu.wbresearch.com/.
At the London Bridge Hospital today, the 100th patient to receive the ExoVasc support was operated on successfully and now has their personalised external aortic root support in place to prevent further dilatation of their ascending aorta. Commenting on this milestone, Peter Gibson – CEO of Exstent Ltd – said: “It is encouraging now to see more centres adopting this new approach to the management of aortic dilatation. Patients have a right to be informed on all the options available in the surgical management of their condition, and for most of those aware of the PEARS approach this is their preferred option.”